MedPath

A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL

A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL logo
🇮🇹Italy
Ownership
Private
Employees
1K
Market Cap
-
Website
http://www.menarini.com

Clinical Trials

3

Active:1
Completed:2

Trial Phases

2 Phases

Phase 1:1
Not Applicable:2

Drug Approvals

7

NMPA:4
CIMA_AEMPS:2
EMA:1

Drug Approvals

Ketoprofen Gel

Product Name
法斯通
Approval Number
国药准字HJ20150425
Approval Date
Aug 7, 2024
NMPA

Ketoprofen Gel

Product Name
法斯通
Approval Number
国药准字HJ20140960
Approval Date
Aug 7, 2024
NMPA

Ketoprofen Gel

Product Name
法斯通
Approval Number
国药准字HJ20140959
Approval Date
Aug 7, 2024
NMPA

Otilonium Bromide Tablets

Product Name
斯巴敏
Approval Number
H20140903
Approval Date
Dec 27, 2019
NMPA

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 1
1 (33.3%)

Effect of an Antioxidants Mix on Cognitive Performance and Well Being: The Bacopa, Licopene, Astaxantina, Vitamin B12

Not Applicable
Completed
Conditions
Cognitive Dysfunction
First Posted Date
2019-01-31
Last Posted Date
2020-07-27
Lead Sponsor
A. Menarini Industrie Farmaceutiche Riunite S.r.l.
Target Recruit Count
80
Registration Number
NCT03825042
Locations
🇮🇹

U.O.C. Geriatria e Lungodegenza - P.O. SS Filippo e Nicola di Avezzano, Avezzano, L'Aquila, Italy

Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels

Not Applicable
Completed
Conditions
Hypercholesterolemia
First Posted Date
2018-11-13
Last Posted Date
2019-10-14
Lead Sponsor
A. Menarini Industrie Farmaceutiche Riunite S.r.l.
Target Recruit Count
88
Registration Number
NCT03739242
Locations
🇮🇹

Policlinico S.Orsola - Malpighi Medicina Interna Borghi, Bologna, Italy

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.